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InTRODUcTIOn
Infections due to viral hepatitis are systemic diseases caused 
by viruses A–E that mostly involve the liver.[1] It is a DNA virus 
which belongs to the family Hepadnaviridae. The virus was first 
discovered as ‘Australian antigen’ and later named hepatitis B 
surface antigen (HBsAg) in the blood of patients. Hepatitis B e 
antigen (HBeAg) was discovered later as a marker for patients 
at a high risk for transmission of the disease.[2]
Infection caused by hepatitis B virus (HBV) is a serious 
public health problem causing about two billion infections 
worldwide.[3] Transmission is commonly through blood 
transfusion, blood products, body fluids (urine, semen, 
sweat, saliva, and tears), use of contaminated needles, 
vertical transmission (mother to child through infected birth 
canal), and sexual contact.[1] Neonates born of chronically 
infected	 mothers	 have	 a	 70–90%	 risk	 of	 the	 infection	
progressing to a chronic phase.[3]
Most countries in Africa have a high HBV endemicity, 
with the exception of Morocco and Tunisia, which have 
intermediate endemicity.[4]	A	prevalence	rate	of	10%	of	HBV	
was found among pregnant women in Hong Kong,[3]	12%	in	
Taiwan,[5]	and17.3%	in	Burkina	Faso.[6]
A b s t r A c t
Background: Pregnant women infected with hepatitis B virus (HBV) can transmit the infection to their fetuses and newborns. 
Neonates who contract the HBV have about 90% risk of developing chronic HBsAg carriage (HBsAg: hepatitis B surface antigen) 
and chronic liver disease. Neonatal immunization interrupts this vertical and perinatal transmission. Objectives: To determine 
the seroprevalence of HBsAg among pregnant women attending the antenatal clinic at Aminu Kano Teaching Hospital (AKTH) 
and to identify potential risk factors associated with HBV infection. Materials and Methods: A case control study was conducted 
involving a total of 303 pregnant women attending the antenatal clinic at AKTH and 303 nonpregnant women of childbearing age. 
Blood sample was collected from each woman and the serum tested for the presence of HBsAg using latex rapid agglutination 
slide test kit (Cal‑Tech Diagnostic Inc., USA) in the laboratory of the hospital. Reactive samples were stored at ‑20ºC and further 
confirmed for HBsAg using enzyme-linked immunosorbent assay (ELISA) kits (Bio-Rad, France). HBsAg-positive samples were 
tested for hepatitis B e antigen (HBeAg) using ELISA kits (Orgenics, Israel). A pretested, structured questionnaire was used for 
the collection of sociodemographic data and possible risk factors. Results: The prevalence of HBsAg among pregnant women 
and nonpregnant women were 7.9 and 7.6%, respectively. There was no statistically significant difference in the prevalence of 
HBsAg in pregnant and nonpregnant women. The presence of HBeAg was statistically significant among both pregnant and 
nonpregnant women who tested positive for HBsAg. The risk factors associated with HBV infection were blood transfusion, ear 
piercing, history of an affected sibling with HBV infection, tattooing, and abortion among pregnant women. Conclusion: The 
prevalence of HBsAg in this study was not statistically different in pregnant and nonpregnant women. There was a high level 
of HBeAg infection among pregnant women who tested positive for HBsAg. History of an affected sibling with HBV infection, 
tattoo, and abortion were significant risk factors for HBV infection.
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Nigeria is classified among the group of countries endemic 




among patients attending all clinics at the Aminu Kano 
Teaching Hospital (AKTH).[12]
When a pregnant woman is infected with HBV, there 
is	 a	 chance	 she	 may	 infect	 her	 fetus;	 10–20%	 of	 women	
seropositive for HBsAg transmit the virus to their 
neonates.[13] In women who are seropositive for both HBsAg 
and HBeAg, mother-to-child transmission is approximately 
90%.[14,15]	 Infected	 neonates	 have	 an	 almost	 90%	 risk	 of	
chronic liver disease (CLD) and also the chance of spreading 
the disease to siblings and to the community.[13] Similarly, 
when pregnant women are infected, they constitute a 
serious health risk not only to their unborn child but also 
the society at large.[13]
Risk factors include occupational exposure, ethnicity, and 
history of sexually transmitted infection, blood transfusion, 
and exposure to hepatitis.[13] The objectives of this study 
was to determine the seroprevalence of HBV carriers and 
the risk factors among pregnant women.
MATeRIALs AnD MeTHODs
This was a case control study carried out at AKTH, a tertiary 
health institution in Kano state, Northwest Nigeria. The 
study population comprised all pregnant women booked 
for antenatal care at AKTH between January and April 2011. 
Nonpregnant women of childbearing age attending the 
gynecology clinic at AKTH were recruited as the control group. 
Women below the age of 18 years were part of our exclusion 
criteria and those who knew their status as HBsAg-positive 
were excluded; the seroprevalence was not calculated in this 
group. In the control group, women above the age of 49 years 
and those discovered pregnant were also excluded.
Sample size estimation
The formula for determining sample size for the comparative 
study was used. Thus the formula:
n = (Zα +Zβ)2 (P1q1 +P2q2) 
(P2 - P1)
2
n = minimum sample size
Zα	=	Standard	normal	deviate	set	at	95%	confidence	
level = 1.96 
Zβ =  Power of the test to detect difference set at 
80%	confidence	level		
P1 = Prevalence of hepatitis B surface antigen among 
pregnant women (obtained from a previous study)[16]
=2.2%
P2 = Prevalence of hepatitis B surface antigen among 
nonpregnant women of childbearing age (obtained from a 
previous study).[17]
=8.9%
q1 = complementary probability (1-p1) = (1-0.022) =  0.978
q2 = complementary probability (1-p2) = (1-0.089) = 0.911
n = 179.18129
So, the minimum sample size was 180 in each group. 
To account for incomplete responses, all 303 consenting 
pregnant women and corresponding controls from the 
gynecology clinic were recruited for the study. 
Sampling and data collection
The recruitment was by a simple random sampling method 
of consenting pregnant women and nonpregnant women of 
childbearing age, which make it a case control study.
Questionnaires were structured and pretested. The authors 
and other resident doctors in the antenatal and gynecology 
clinic administered the questionnaires to the participants 
after an orientation.
Sociodemographic factors of age, marital status, ethnicity, 
educational status, and the gestational age of the 
pregnancy (for pregnant women only) were recorded on the 
questionnaires.
Potential risk factors including dental procedures, surgical 
procedures, sharing sharp objects, HBV vaccination 
status, use of contraceptives, tattooing, unsafe injections, 
abortion, blood transfusion, and ear piercing were carefully 
documented.
A blood sample (4 mL) was collected from all participants 
from the antecubital vein, using plastic disposable syringes. 
Each sample for a particular participant was coded for 
easy identification and transferred to a clean test tube and 
allowed for natural clotting. After clotting naturally, each 
sample was separated by centrifugation at 1,500 revolutions 
per minute (rpm). Part of the sera collected was tested for 
HBsAg using latex rapid agglutination slide test kits (Cal-
Tech Diagnostic Inc., USA) in the laboratory of the hospital 
where the sample was collected.
Reactive samples were stored at -20°C and further 
reconfirmed for HBsAg using commercially available ELISA 
kit (Bio-Rad, France) in the laboratory. HBsAg-positive 
samples were tested for HBeAg using ELISA kit (Orgenics, 
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Israel). Ethical approval was granted by the ethical 
committee of AKTH, Kano.
Data analysis
Data were entered into a personal computer and analyzed 
using SPSS version 17 computer software. Comparison 
of categorical variables was done using the chi-square 
test, whereas P value 0.05 or less was considered 
significant.
ResULTs
During the study period, a total of 303 consenting pregnant 
women and 326 consenting nonpregnant women from the 
antenatal and gynecology clinics of AKTH were enrolled, 
respectively. Twenty-three nonpregnant women from the 
gynecology clinic were dropped out of the control group 
because they did not match the age group.
Table 1 shows the sociodemographic characteristics of the 
subjects. The mean age [standard deviation (SD)] of the 
cases was 27.6 (5.8) years and the mean age of the controls 
was 27.0 (5.8). The study showed no significant difference 
in the distribution of ages between cases and controls 
(P=0.189,). The age group with the highest frequency 
among	cases	106/303	(35.0%)	and	controls	133/303	(43.9%)	




Majority in both groups are Hausas, and have some level of 
secondary education. They are mostly housewives. Others 
in the occupation group include trade like fish farming, 
cattle rearing, and poultry. The businesswomen among 
them usually buy goods and sell.
Figure 1 shows the distribution of pregnant women 
based	 on	 the	 trimester	 of	 pregnancy.	 Twenty‑one	 (6.9%)	
(21/303)	were	 in	 the	 first	 trimester,	 174/303	 (57.4%)	were	
in	the	second	trimester,	and	108	(35.6%)	were	in	the	third	
trimester.
Twenty‑four	 (7.9%)	 out	 of	 303	 pregnant	 women	 tested	
positive	for	HBsAg.	Fifteen	(62.5%)	out	of	the	24	who	tested	
positive for HBsAg were also positive for HBeAg. In the 
control	 group,	 23	 (7.6%)	 out	 of	 303	 gynecologic	 patients	
who participated in the study tested positive for HBsAg. Six 
(26.1%)	out	of	the	23	who	tested	positive	for	HBsAg	were	
also positive for HBeAg.
There was no statistically significant difference in the 
prevalence of HBsAg in pregnant women and nonpregnant 
women (P=0.879).
There was a statistically significant difference of HBeAg 
presence among the pregnant women who tested positive 
for HBsAg (P<0.001).
There was also a statistically significant difference of HBeAg 
presence among nonpregnant women who tested positive 
for HBsAg (P<0.001).
Table 2 depicts the seroprevalence of HBsAg among age 




Table 1: Sociodemographic characteristics of case and control 
groups
Cases Controls
Frequency (n) (%) Frequency (n) (%)
Age group
18‑24 106 35.0 133 43.9
25‑29 86 28.4 74 24.4
30‑34 77 25.4 63 20.8
35‑39 20 6.6 19 6.3
40‑44 14 4.6 14 4.6
45‑49 0 0.0 0.0 0.0
Total 303 100.0 303 100.0
Ethnicity
Hausa 216 71.3 207 68.3
Igbo 24 7.9 28 9.2
Yoruba 24 7.9 5 1.7
Others 39 2.9 63 20.8
Marital status
Married 297 98.2 238 78.5
Single Nil Nil 33 10.9
Divorced/separated 6 2 16 5.3
Widowed Nil Nil 16 5.3
Marriage setting
Monogamy 213 70.3 208 68.6
Polygamy 90 29.7 43 14.2
Unmarried Nil Nil 52 17.2
Education 
Primary 66 21.8 16 5.3
Secondary 159 52.4 135 44.6
Tertiary 72 23.8 87 28.7
Qur’anic (only) 6 2.0 65 21.4
Occupation
Housewives 161 53.1 147 48.5
Businesswomen 27 8.9 79 26.1
Professionals 32 10.6 20 6.6
Artisans 20 6.6 3 1.0
Students 54 17.8 6 1.7
Others 9 3.0 6 2.0
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groups of both the control and study groups. Except for 
the age groups of 35–39 and 40–44 years, at least one 
seropositive case for HBsAg was found in all age groups. 
The	highest	age‑specific	prevalence	of	10.5%	(9/86)	was	 in	
the age group of 25–29 years in the study group (cases) 
whereas	 in	 the	 control	group	 (35.7%)	 (5/14),	 it	was	 in	 the	
age group of 40–44 years. There was no linear relationship 
between the prevalence of HBsAg and age in both the study 
and control groups. There was no statistically significant 
difference in HBsAg between the age groups among the 
study group (pregnant women) (P=0.426). However, there 
was a statistically significant difference in HBsAg between 
the age groups among the controls (P=0.001).
Hepatitis B surface antigen
Table 3 shows the sociodemographic characteristics of 
the study and control groups. A high proportion of HBsAg 
was	noted	among	Igbos	 (12.5%)	 (3/24)	 in	the	study	group.	
However, there was no statistically significant difference 
between the ethnic groups (P=0.70). In the control group, a 
high	proportion	of	HBsAg	noted	among	Igbos	(17.9%)	(5/28)	
was statistically significant between the ethnic groups 
(P=0.017).
An	alarming	 figure	of	 8.1%	 (24/297)	was	 also	 seen	 among	
pregnant women who were married, indicating a high 
prevalence of HBsAg in the group. There was no statistically 
significant difference of HBsAg between the marital statuses 
(P=0.468).
In the control group, a high prevalence of HBsAg was 
noted among the ‘separated’ women which was statistically 
significant (P<0.001).
A high proportion of HBsAg seen in the polygamous 
setting	of	marriage	(16.7%)	(15/90)	in	the	study	group	was	
statistically significant (P<0.001). In the control group, a 
high proportion of HBsAg was seen among the unmarried 
which was also statistically significant (P=0.014).
A high proportion of HBsAg was revealed among those 
with	 a	 secondary	 level	 of	 education	 (11.4%)	 (18/159)	
in the study group. This was however not statistically 
significant (P=0.141). In the control group, the proportion 
was highest among those that did not have any form of 
education	(21.4%)	(3/14)),	which	was	statistically	significant	
(P=0.040).
HBsAg was more prevalent among professionals/executives 
(12.5%)	 (4/32)	 in	 the	 study	 group	but	was	not	 statistically	
significant (P=0.477). In the control group, HBsAg had the 
highest proportion among the business class, but was not 
statistically significant (P=0.617).
Eighteen	(10.3%,	18/174)	pregnant	women	in	their	second	
trimester	 tested	 positive	 for	 HBsAg,	 6/21	 (5.6%)	 pregnant	
women in their third trimester tested positive for HBsAg; 
none tested positive for HBsAg in the first trimester 
of pregnancy. However, occurrence of HBsAg was not 
statistically significant (P=0.133).
Table 4 depicts the potential risk factors and prevalence 
of HBsAg among both cases and controls with risk factors. 
Only tattooing, abortion, and history of an affected sibling 
with hepatitis B infection among the pregnant women were 
found to have a significant association with HBsAg (P=0.002, 
P<0.001, P=0.001, respectively). In the control group, surgical 
procedure, use of unsterilized sharp instruments, abortion, 
blood transfusion, ear piercing, and previous infection with HBV 
were significantly associated with serum hepatitis (P<0.001 
P=0.046; P<0.001 P=0.001; P=0.020; P<0.001, respectively).
DIscUssIOn
The overall prevalence of HBsAg among pregnant women 
Table 2: Prevalence of HBsAg in relation to age of the 
pregnant women and controls
Age Cases Controls
No. tested Positive  
results (%)
No. tested Positive  
results (%)
18‑24 106 8 (7.5) 133 11 (8.3)
25‑29 86 9 (10.5) 74 3 (4.1)
30‑34 77 7 (9.1) 63 2 (3.2)
35‑39 20 0 (0) 19 2 (10.5)
40‑44 14 0 (0) 14 5 (35.7)
Total 303 24 303 23
HBsAg ‑ Hepatitis B surface antigen
Table 3: Prevalence of HBsAg in relation to sociodemographic 
characteristics of cases and controls
 Cases Controls
No. tested Positive 
results (%)
No. tested Positive 
results (%)
Ethnic group
Hausa 216 21 (9.7) 207 18 (8.7)
Igbo 24 3 (12.5) 28 5 (17.9)
Yoruba 24 0 (0.0) 5 0 (0.0)
Others 39 0 (0.0) 63 0 (0.0)
Marital status
Single – – 33 0 (0.0)
Married 297 24 (8.1) 238 14 (5.9)
Divorced/separated 6 0 (0.0) 16 5 (62.5)
Widowed – – 16 4 (25.0)
Educational status
None 0 0 (0.0) 14 3 (21.4)
Primary 66 3 (4.5) 16 0 (0.0)
Secondary 159 18 (11.3) 135 10 (7.4)
Tertiary 72 3 (4.2) 87 3 (3.4)
Qur’anic 6 0 (0.0) 51 7 (13.7)
Occupation
Housewife 161 15 (9.3) 147 11 (7.5)
Businesswoman 27 1 (3.7) 79 9 (11.4)
Professional 32 4 (12.5) 20 0 (0.0)
Artisan 20 0 (0.0) 3 0 (0.0)
Student 54 4 (7.4) 43 3 (7.0)
Others 9 0 (0.0) 5 0 (0.0)
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was	 7.9%,	 whereas	 the	 prevalence	 among	 nonpregnant	
women	of	child	bearing	age	was	7.6%.	These	findings	were	
similar	to	those	from	Zaria,	Northwest	Nigeria	(8.3%),[11,15] but 
higher than the findings from Port Harcourt, South Nigeria 
(4.3%),[18] and Ilorin,[9] North Central Nigeria. However, the 
prevalence rate in our study was lower than the prevalence 
found	 in	 Maiduguri	 (11.6%),[9] Northeast Nigeria. The 
prevalence in both groups also depicts a trend that follows 
a low prevalence from the southern parts of the country 
increasing	 to	 its	 highest	 of	 11.6%	 in	 the	 northern	 parts	
(Maiduguri). Sociodemographic factors, most importantly 
the level of health education on prevention, may play a 
role in the southern parts of the country. Other reasons 
include higher economic status, higher educational level, 
early seeking of health-care assistance, and better effective 
utilization of these health-care facilities. 
There was no statistically significant difference of HBsAg in 
pregnant and nonpregnant women in the study. This could 
be attributed to similar sociodemographic factors among 
pregnant women and nonpregnant women of child bearing 
age in the study and almost equal exposure to the potential 
risk factors in the study. Pregnancy per se is not a potential 
risk factor for HBV infection. 
HBeAg	 seroprevalence	 of	 62.5%	 among	 pregnant	 women	
who	 tested	 positive	 for	 HBsAg	 and	 26.01%	 among	
nonpregnant women attending the gynecology clinic at 
AKTH was alarming. It implies that five out of eight hepatitis-
positive pregnant women had HBeAg as did almost one 
out of four nonpregnant women. As such, there is a high 
risk of chronic infection and vertical transmission of HBV 
from mother to child. Although there was no plausible 
explanation for the large difference in HBeAg rates between 
pregnant and nonpregnant women, health-care providers 
attending to these pregnant women should be aware of this 
high infectivity and provide measures to prevent horizontal 
transmission. This finding is higher than what was reported 
by Mbaawuaga and colleagues in Makurdi, North Central 
Nigeria	 (3.3%)[19]	 and	 1.39%[10] reported by Harry and 
colleagues in Maiduguri, Nigeria. The prevalence rate from 
our	findings	is	also	significantly	higher	than	the	figure	of	0.8%	
reported from other parts of Africa (Zimbabwe) by Madzime 
and colleagues.[20] Therefore, the issue of mother-to-child 
transmission of HBV infection cannot be ignored in AKTH.
The prevalence of HBsAg has no linear relationship in both 
case and control groups. There was no HBsAg detected 
in the serum of women in the 35–39 year and 40–44 year 
groups among pregnant women; all other age groups had 
HBsAg detected in their serum. A similar finding was also 
reported by Awole and colleagues[21] in Ethiopia.
The age group of 25–29 years had the highest prevalence of 
10.5%	in	the	study	group.	The	high	prevalence	among	this	age	
group was consistently reported in several other studies.[22-24] 
This is partly because HBV infections are mainly acquired 
following vertical transmission or through sexual contact, 
and this group is the most active age group sexually. The 
positivity rate of HBsAg varies widely among ethnic groups 
with	the	highest	prevalence	recorded	among	Igbos	(12.5%)	in	
the	study	group	and	17.9%	in	the	control	group	even	though	
this was not statistically significant. A high prevalence of 
HBsAg was revealed among those who were married in the 
control	group	(8.1%).	There	was	no	case	of	HBsAg	among	the	
divorced women and the single nonpregnant women. This 
was similar to the findings of Rabiu and colleagues[25] in Lagos, 
Nigeria. This could be due to the fact that HBV is sexually 
transmitted and the duration of sexual activity, number of 
sexual partners, and history of sexually transmitted infections 
determine the prevalence of HBV infections.[18] 
In	the	study	group,	a	high	prevalence	of	HBsAg	(11.3%)	was	
recorded among those with secondary level of education, 
similar	 to	 the	 finding	 of	 34	 (55.7%)	 in	 Lagos.	 Ndams	
and colleagues[23] found an inverse association between 
Table 4: Potential risk factors and prevalence of HBsAg amongst the study and control groups
Risk factors Cases Controls
No. No. HBsAg+ (%) P value No. No. HBsAg+ (%) P value
Dental procedure 59 3 (5.1) P=0.369 50 4 (8.0) P=0.905
Surgical procedure 38 3 (7.9) P=0.995 128 20 (15.6) P<0.001
Sharp instruments 32 0 (0.0) P=0.790 62 1 (1.6) P=0.046
Injectable contraceptive 50 7 (14.0) P=0.082 61 3 (4.9) P=0.378
Loop 42 3 (7.1) P=0.841 47 3 (6.4) P=0.734
Tattooing 93 14 (15.1) P=0.002 42 1 (2.4) P=0.170
Unsafe injection 19 0 (0.0) P=0.187 15 0 (0.0) P=0.255
Abortion 102 18 (17.6) P<0.001 129 19 (14.7) P<0.001
Blood transfusion 40 6 (15.0) P=0.075 100 15 (15.0) P=0.001
Ear piercing 242 19 (7.9) P=0.929 249 23 (9.2) P=0.020
Other risk factors 14 3 (21.4) P=0.550 – – –
No risk factors 12 1 (8.3) P=0.957 23 0 (0.0) P=0.153
Miscellaneous 5 1 (20.0) P=0.313 – – –
Previous infection 8 0 (0.0) P=0.400 11 6 (54.5) P≤.0.001
Affected sibling 7 3 (42.9) P=0.001 15 3 (20.0) P=0.063
Total 763 932
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educational status and HBsAg positivity, with less educated 
women showing the highest prevalence of HBsAg, indicating 
the positive influence of education and public enlightment/
awareness on the carrier rate of HBV infection.
Pregnant women in the second trimester had the highest 
prevalence	 of	 HBsAg	 (10.2%),	 followed	 by	 third	 trimester	
with	 a	 figure	 of	 5.6%.	 None	 tested	 positive	 for	 HBsAg	 in	
the first trimester. This is similar to the findings of Ndams 
and colleagues[23] in other parts of Nigeria, where pregnant 
women in the second trimester had the highest prevalence 
of	HBsAg	of	13.4%	followed	by	the	third	and	first	trimesters,	
respectively.
Among the potential risk factors, only tattoo, abortion, and 
history of an affected sibling with HBV infection among 
the pregnant women were found to have a significant 
association with HBsAg. This was similar to the findings in 
Ethiopia[21,26] where tattooing and abortion were reported 
as significant risk factors for HBV infection among pregnant 
women.
The association of HBV infection and abortion could be 
related to the fact that abortion is directly related to sexual 
activity and sexually active women have a higher chance 
of getting the infection especially those in a polygamous 
setting. A history of an affected sibling with HBV infection 
implies that the woman was a chronic carrier of the virus 
and had infected her sibling or the sibling had infected her. 
Surgical procedure, use of unsterilized sharp instruments, 
abortion, blood transfusion, ear piercing, and previous 
infection with HBV were significantly associated with serum 
hepatitis. In this study, most of the risk factors correlated 
poorly with the serum hepatitis. This is not an uncommon 
finding as other studies have indicated that the sensitivity of 
Center for Disease Control and Prevention (CDC) risk factors 
for screening pregnant women for HBsAg ranges between 
35	 and	 65%.[27] The findings that only three risk factors 
among pregnant women were significantly associated with 
HBV infection clearly indicates the inconsistency of these 
risk factors and as such, screening pregnant women on the 
basis of risk factors may be of little help in the detection of 
HBsAg and prevention of neonatal transmission; hence the 
need for routine antenatal screening of all pregnant women.
Data on the numbers of excluded women who knew their 
status as HBsAg positive were not included in the calculation. 
This may probably imply that the actual seroprevalence of 
this hospital population may be higher. These shortcomings 
will be addressed in further studies. Furthermore, some 
sociodemographic variables which were not included in this 
study like sexual activity will be given adequate attention 
and this will include performing a multivariate analysis.
The prevalence of HBsAg among the pregnant women 
attending antenatal care at AKTH is not significantly different 
from the nonpregnant women. However, there was a high 
level of HBeAg among pregnant women who tested positive 
for HBsAg. Health-care providers should therefore ensure 
that all efforts are made toward the prevention of vertical 
and horizontal transmission. These will guarantee optimal 
feto maternal outcome and healthy health-care workforce, 
and indeed smoothen the ride toward the developmental 
goals of the millennium.
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